COVID-19: The revised testing strategy of the ICMR
The story so far: With the highly transmissive Omicron variant now recorded in most States, and given the mild symptoms seen
Read More
Author: Prasad Ravindranath
Will the pig-to-human heart operation lead to a new approach to organ transplantation?
The story so far: On January 7, David Bennett, a 57-year-old from Baltimore, Maryland, U.S. became the first person to receive a
Read More
COVID-19: Covaxin booster increases neutralising antibodies, study finds
The control arm of the study had 93 participants and the intervention arm had 91 participants, but most of these people were under 55 years
Read More
COVID-19: Booster doses only mitigate disease severity, do not fully prevent infection
Though 90.8 million people above 60 years, 9.7 million health-care workers and nearly 17 million frontline workers have received the
Read More
COVID-19: Are there clinical trial data to support a homologous vaccine booster?
This means those who have received Covishield as their first and second dose will receive Covishield as their third dose.
Read More
Conflicting signals from drug regulator, COVID-19 national task force
“Considering the emergency and unmet medical need in Covid-19, the SEC on December 27 recommended for grant of permission to
Read More
COVID-19: Even if mild, Omicron variant can overwhelming health-care settings
Huge percentage of the population in India got infected when the Delta variant raged through the country. Studies from other
Read More
Does Covaxin have WHO’s approval for use in children?
While clearly stating that teenagers aged 15 years or more (all those whose birth year is 2007 or before) will
Read More
COVID-19: India widens the vaccine safety net by immunising teenagers above 15 years
With all adults aged 18 years and above already being covered, the inclusion of teenagers has reduced the eligibility age
Read More
COVID-19: The basis on which India approved precaution dose remains unclear
He said the primary focus of the government was on giving a second dose of the vaccine to make people
Read More
COVID-19: India should prepare for the worst with Omicron
The World Health Organization said the number of COVID-19 cases recorded globally shot up by 11% last week (December 20-26)
Read More
Two COVID-19 antivirals get FDA nod for emergency use
Unlike in the case of remdesivir, both the drugs — Pfizer’s paxlovid and Merck’s molnupiravir — are oral pills and
Read More
Is the current testing, sequencing strategy missing Omicron cases in India?
A November 30, 2021 circular from the health ministry clearly mentions that effective December 1, all passengers arriving from specified
Read More